Last reviewed · How we verify
AK104 plus Carboplatin and Pemetrexed
AK104 plus Carboplatin and Pemetrexed is a Small molecule drug developed by Akeso. It is currently in Phase 1 development.
At a glance
| Generic name | AK104 plus Carboplatin and Pemetrexed |
|---|---|
| Sponsor | Akeso |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- AK112 and AK104 With or Without Chemotherapy in Advanced Non-small Cell Lung Cancer (PHASE1, PHASE2)
- Efficacy and Safety of AK104 Combined With Chemotherapy and Recombinant Human Adenovirus 5 Injection in Cervical Cancer (PHASE2)
- A Study of AK104 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (PHASE1, PHASE2)
- Study of Cadonilimab Combined With Bevacizumab and Standard Chemotherapy as First Line Therapy in Unresectable Pleural Mesothelioma (PHASE2)
- Cadonilimab (AK104) Plus Chemotherapy as First-line Treatment in Non-squamous Non-Small Cell Lung Cancer (NSCLC) Patients With Programmed Cell Death Ligand 1 (PD-L1) Negative (PHASE2)
- A Study of AK104/Tislelizumab With Chemotherapy as First-line Treatment in PD-L1 TPS < 1% Non-small Cell Lung Cancer (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- AK104 plus Carboplatin and Pemetrexed CI brief — competitive landscape report
- AK104 plus Carboplatin and Pemetrexed updates RSS · CI watch RSS
- Akeso portfolio CI
Frequently asked questions about AK104 plus Carboplatin and Pemetrexed
What is AK104 plus Carboplatin and Pemetrexed?
AK104 plus Carboplatin and Pemetrexed is a Small molecule drug developed by Akeso.
Who makes AK104 plus Carboplatin and Pemetrexed?
AK104 plus Carboplatin and Pemetrexed is developed by Akeso (see full Akeso pipeline at /company/akeso).
What development phase is AK104 plus Carboplatin and Pemetrexed in?
AK104 plus Carboplatin and Pemetrexed is in Phase 1.
Related
- Manufacturer: Akeso — full pipeline
- Compare: AK104 plus Carboplatin and Pemetrexed vs similar drugs
- Pricing: AK104 plus Carboplatin and Pemetrexed cost, discount & access